TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Mias Lymfterapi AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
69
|
84
|
60 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
28
|
33
|
12 |
| EBITDA |
27
|
33
|
12 |
| Total assets |
186
|
166
|
143 |
| Current assets |
186
|
166
|
143 |
| Current liabilities |
18
|
21
|
14 |
| Equity capital |
168
|
145
|
129 |
| - share capital |
34
|
33
|
36 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
90.3%
|
87.3%
|
90.2% |
| Turnover per employee |
69
|
84
|
60 |
| Profit as a percentage of turnover |
40.6%
|
39.3%
|
20.0% |
| Return on assets (ROA) |
15.1%
|
19.9%
|
8.4% |
| Current ratio |
1033.3%
|
790.5%
|
1021.4% |
| Return on equity (ROE) |
16.7%
|
22.8%
|
9.3% |
| Change turnover |
-15
|
29
|
-8 |
| Change turnover % |
-18%
|
52%
|
-12% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.